Vir Biotechnology, Inc. (NASDAQ:VIR) is one of the best low priced biotech stocks to invest in. On April 13, Vir Biotechnology, Inc. (NASDAQ:VIR) announced that the first patient had been dosed in one ...

BioMedWire Editorial Coverage: Biotechnology is undergoing a quiet but profound transformation, one that is reshaping how investors understand value in a sector ...

Virtual event highlights cutting‑edge innovations driving advances in healthcare, sustainability, and emerging ...

Food technology and ingredients company Kerry Group has opened its expanded biotechnology manufacturing facility in Carrigaline in Co Cork, significantly increasing its capacity to produce lactase ...

April 20, 2026) – Huxley Health Inc. (“Huxley” or the “Company”), together with its Aerasyn Biotech division, a biotechnology platform advancing next-generation therapeutics through AI-guided ...

Theriva Biologics (TOVX) stock surged 63% after Phase 2b trial data revealed VCN-01 plus chemo improved survival in ...

Vir Biotechnology has dosed the first patient in one of three expansion cohorts in its ongoing Phase I clinical trial of ...

Cathie Wood's ARK bought $2.5M in Netflix (NFLX) shares after earnings dip, sold Circle and Bullish crypto stocks, and added ...

Eli Lilly is in advanced talks to acquire biotech firm Kelonia ‌Therapeutics for more than $2 billion, the Wall ‌Street ...

ViewTech Borescopes, a leading provider of remote visual inspection (RVI) equipment, is returning to exhibit at INTERPHEX, ...

The Antingaw, a rare rock-boring shipworm from Bohol, vies for International Mollusc of the Year. Vote now to win genome ...

SingleCell Biotechnology, a biotechnology company developing technologies to measure tumor cell behavior at single-cell ...